Recent SILO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 09/18/2024 08:19:02 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/18/2024 08:17:30 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/18/2024 08:15:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 10:46:07 AM
- Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD • GlobeNewswire Inc. • 09/10/2024 10:35:00 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 08/21/2024 09:20:42 PM
- Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic • GlobeNewswire Inc. • 08/14/2024 06:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:30:38 PM
- Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide • GlobeNewswire Inc. • 08/07/2024 12:13:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 07/26/2024 08:17:36 PM
- Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference • GlobeNewswire Inc. • 07/26/2024 12:20:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/25/2024 08:30:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2024 09:00:38 PM
- Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/22/2024 08:45:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/22/2024 10:06:13 AM
- Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/19/2024 12:01:00 PM
- Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15 • GlobeNewswire Inc. • 07/18/2024 12:25:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/17/2024 08:45:59 PM
- Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic • GlobeNewswire Inc. • 07/16/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:15:15 PM
- Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders • GlobeNewswire Inc. • 07/08/2024 12:45:00 PM
- Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety • GlobeNewswire Inc. • 06/26/2024 12:50:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM